MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'iloperidone'. Sun, 11 Oct 2009 21:24:23 +0100 http://www.medworm.com/index.php?rid=2398856&cid=t_158321_111_f&fid=36048&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAHeartyLife%2F%7E3%2FvKNFgNsDr2I%2F The United States FDA has granted marketing approval to a new drug to help treat schizophrenia. Called Fanapt (iloperidone), the medication is intended to treat adults with schizophrenia while in the acute phases. It isn’t yet known how long they should be kept on the medication once the acute phases is over, but researchers agree that if the patient is responding, continuing with the treatment is encouraged. According to a company press release , “The approval was supported by two placebo-controlled Phase III clinical studies comparing Fanapt(TM) to placebo and active control in patients with schizophrenia, as well as safety data from more than 3,000 patients.” Schizophrenia is a fairly common mental illness, estimated to strike one out of every 100 people in North Amer... A Hearty Life blogs http://www.medworm.com/rss/comments.php?id=2398856 Sat, 09 May 2009 15:02:46 +0100 2398856 http://www.medworm.com/index.php?rid=1660748&cid=t_158321_109_f&fid=34800&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FClinicalPsychologyAndPsychiatryACloserLook%2F%7E3%2F348623650%2Filoperidone-vanda-shareholder-train.html Many months back, when shares of Vanda Pharmaceuticals were going for 29 bucks, I warned y'all: Their main product, iloperidone, showed all the signs of being a dud. It has been in the clinical trials stage of development for about a decade and it had yet to receive FDA approval. Um, if a drug was of significant benefit, do you really think it would have been in late-stage development for 10 years? In December 2006, I wrote: As for iloperidone, one article forecasted that it would hit the market in 2001! Further digging indicated that Titan, which holds the license for iloperidone (to some extent, anyway), was in a spot of trouble for allegedly hiding the drug’s side effect profile. In 1997, according to a report filed with the SEC, “the Company does not have the funds necessary to co... Clinical Psychology and Psychiatry: A Closer Look blogs http://www.medworm.com/rss/comments.php?id=1660748 Mon, 28 Jul 2008 17:52:00 +0100 1660748 http://www.medworm.com/index.php?rid=1054848&cid=t_158321_97_f&fid=35050&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmaGazette%2F%7E3%2F191462750%2Ffda_drug_approval_news.html Vanada Pharmaceuticals has announced that its drug, iloperidone, has been accepted for U.S. Food and Drug Administration New Drug Application (NDA). Iloperidone is an investigational atypical antipsychotic for the treatment of schizophrenia.In other FDA news, Watson Pharmaceuticals Inc announced that it received final approval on its ANDA for Oxycodone Hydrochloride and Ibuprofen tablets in the 5/400 mg strengths. Waston's product is the generic equivalent of Forest Laboratories Inc.'s Combunox which is used for the short term (no more than 7 days) treatment of acute, moderate to severe pain.The FDA has accepted filing of a NDA for Schering-Plough's asenapine, a fast-dissolving, sub-lingual tablet for schizophrenia and acute mania associated with Bipolar I Disorder. To dat... PharmaGazette blogs http://www.medworm.com/rss/comments.php?id=1054848 Tue, 27 Nov 2007 20:00:38 +0100 1054848